- Home
- QURE vs GAIN Comparison
QURE vs GAIN Comparison
Compare QURE & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- GAIN
- Stock Information
- Founded
- QURE 1998
- GAIN 2005
- Country
- QURE Netherlands
- GAIN United States
- Employees
- QURE N/A
- GAIN N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- QURE Health Care
- GAIN Finance
- Exchange
- QURE Nasdaq
- GAIN Nasdaq
- Market Cap
- QURE 432.6M
- GAIN 473.7M
- IPO Year
- QURE 2007
- GAIN 2005
- Fundamental
- Price
- QURE $6.65
- GAIN $13.97
- Analyst Decision
- QURE Buy
- GAIN Hold
- Analyst Count
- QURE 6
- GAIN 2
- Target Price
- QURE $19.50
- GAIN $13.50
- AVG Volume (30 Days)
- QURE 846.7K
- GAIN 226.4K
- Earning Date
- QURE 11-05-2024
- GAIN 11-07-2024
- Dividend Yield
- QURE N/A
- GAIN 6.87%
- EPS Growth
- QURE N/A
- GAIN 105.44
- EPS
- QURE N/A
- GAIN 1.99
- Revenue
- QURE $27,707,000.00
- GAIN $89,184,000.00
- Revenue This Year
- QURE $187.60
- GAIN $7.19
- Revenue Next Year
- QURE $51.90
- GAIN $1.22
- P/E Ratio
- QURE N/A
- GAIN $7.03
- Revenue Growth
- QURE N/A
- GAIN 8.04
- 52 Week Low
- QURE $3.73
- GAIN $12.46
- 52 Week High
- QURE $11.35
- GAIN $14.96
- Technical
- Relative Strength Index (RSI)
- QURE 63.87
- GAIN 53.12
- Support Level
- QURE $6.01
- GAIN $13.29
- Resistance Level
- QURE $6.55
- GAIN $14.37
- Average True Range (ATR)
- QURE 0.54
- GAIN 0.24
- MACD
- QURE 0.18
- GAIN -0.01
- Stochastic Oscillator
- QURE 91.67
- GAIN 44.16
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.